Epigenetics Market worth 890.0 Million USD by 2020 - PowerPoint PPT Presentation

Loading...

PPT – Epigenetics Market worth 890.0 Million USD by 2020 PowerPoint presentation | free to download - id: 880e39-ZjNjY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Epigenetics Market worth 890.0 Million USD by 2020

Description:

The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. – PowerPoint PPT presentation

Number of Views:1

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Epigenetics Market worth 890.0 Million USD by 2020


1
MarketsandMarkets Presents
Epigenetics Market by Product Global Forecast to
2020
http//www.marketsandmarkets.com/Market-Reports/ep
igenetics-technologies-market-896.html
2
The report Epigenetics Market by Product
(Modifying Enzymes, DNA Polymerase, Acetylase,
Methyltransferase, Instruments Consumables,
Kit, Bisulphite Conversion Kit, Reagents), by
Research Area (Developmental Biology, Oncology) -
Global Forecast to 2020 provides a detailed
overview of the major drivers, restraints,
challenges, opportunities, current market trends,
and strategies impacting the epigenetics market
along with the estimates and forecasts of the
revenue and market share analysis. Browse 84
market data tables 82figures 158 pages And
in-depth TOC on Epigenetics Market Get The PDF
Brochure For This Report http//www.marketsandma
rkets.com/pdfdownload.asp?id896 The epigenetics
market is expected to reach USD 890.0 Million by
2020 from USD 469.6 Million in 2015, at a CAGR of
13.64 between 2015 and 2020. http//www.markets
andmarkets.com/Market-Reports/urinalysis-systems-m
arket-153479294.html
3
This report segments the global epigenetics
market by product and research areas. The global
market product segments include enzymes,
instruments consumables, kits and reagents.
Enzymes are further subsegmented into
DNA-modifying enzymes, protein-modifying enzymes,
and RNA-modifying enzymes. Instruments
consumables are further subsegmented into mass
spectrometers, next-generation sequencers, qPCRs,
sonicators and other epigenetics instruments
consumables. The research area segments of this
market are developmental biology, drug discovery,
oncology and other research areas. Other research
areas include genome-wide regulatory mechanisms
and research related to several metabolic and
genetic diseases. Request a sample of the
report http//www.marketsandmarkets.com/requests
ample.asp?id896 Major players in the global
epigenetics market are Abcam plc. (U.K),
Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland),
Merck Co. (U.S.), New England Biolabs, Inc.
(U.S.), Sigma-Aldrich Corporation (U.S.), Thermo
Fisher Scientific, Inc., (U.S.), Active Motif
(U.S.), Diagenode, Inc. (Belgium) and Zymo
Research Corporation (U.S.). http//www.marketsan
dmarkets.com/Market-Reports/epigenetics-technologi
es-market-896.html
4
  • The geographic segments included in this report
    are North America, Europe, Asia, and the Rest of
    the World (RoW). North America is further
    subsegmented into the U.S. and Canada. In 2015,
    the North America is expected to command the
    largest share of the global epigenetics market.
    Asia is expected to register the highest growth
    due to high prevalence of cancer, increasing
    research activities by various research
    institutes and increasing R D funding by
    biotechnology and pharmaceutical companies in
    this region.
  • Global Epigenetics Market, by Research Areas
  • Developmental Biology
  • Drug Discovery
  • Oncology
  • Other Epigenetics Research Areas
  • Global Epigenetics Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Asia
  • Rest of the World

http//www.marketsandmarkets.com/Market-Reports/ep
igenetics-technologies-market-896.html
5
Increasing research activities by academic and
research institutes and high prevalence of cancer
will majorly drive the growth of the market.
Other growth factors include the increasing
application for non-oncology diseases and
growing partnership between academic,
biotechnology and pharmaceutical companies. The
new emerging markets such as Brazil, Russia,
India and China will provide opportunities for
market growth. Key Players Major players in
the global epigenetics market are Abcam plc.
(U.K), Illumina, Inc. (U.S.), QIAGEN N.V.
(Netherland), Merck Co. (U.S.), New England
Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation
(U.S.), Thermo Fisher Scientific, Inc., (U.S.),
Active Motif (U.S.), Diagenode, Inc. (Belgium)
and Zymo Research Corporation (U.S.). Speak to
Analyst http//www.marketsandmarkets.com/speakt
oanalyst.asp?id896
http//www.marketsandmarkets.com/Market-Reports/ep
igenetics-technologies-market-896.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/ep
igenetics-technologies-market-896.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel 1-888-600-6441 Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
About PowerShow.com